Literature DB >> 1327524

Human small cell lung cancer expresses the octamer DNA-binding and nervous system-specific transcription factor N-Oct 3 (brain-2).

E Schreiber1, A Himmelmann, U Malipiero, A Tobler, R Stahel, A Fontana.   

Abstract

Small cell lung cancer (SCLC) cells express several characteristics of neuronal cells, including synthesis of neuropeptides and expression of the respective receptors. Establishment and maintenance of the neuronal phenotype of SCLC may depend on expression of gene transcription factors inherent to the central nervous system. The present study shows the nervous system-specific transcription factor N-Oct 3 (brain-2) to be expressed in all 13 SCLC cell lines investigated. Furthermore, N-Oct 3 (brain-2) was also found in SCLC-derived skin metastasis. In contrast, in extracts and RNA of non-SCLC cell lines and non-SCLC tumor tissues, such as lung squamous, large cell, and adenocarcinoma, expression of N-Oct 3 (brain-2) was not detectable. These data support the concept that SCLC cells derive from the neuroectodermal cell lineage since expression of N-Oct 3 (brain-2) protein is highly abundant at the neural tube stage and in the adult restricted to the neuroectodermal cell lineage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327524

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors.

Authors:  Amber V Flora; Cristian A Zambrano; Xavier Gallego; Jill H Miyamoto; Krista A Johnson; Katelyn A Cowan; Jerry A Stitzel; Marissa A Ehringer
Journal:  Brain Res       Date:  2013-07-18       Impact factor: 3.252

2.  Oct-1 interacts with conserved motifs in the human thyroid transcription factor 1 gene minimal promoter.

Authors:  C D Bingle; S Gowan
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer.

Authors:  J M Coulson; C E Fiskerstrand; P J Woll; J P Quinn
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

4.  The Brn-2 transcription factor links activated BRAF to melanoma proliferation.

Authors:  Jane Goodall; Claudia Wellbrock; Timothy J Dexter; Karen Roberts; Richard Marais; Colin R Goding
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

5.  Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin.

Authors:  Jane Goodall; Silvia Martinozzi; Timothy J Dexter; Delphine Champeval; Suzanne Carreira; Lionel Larue; Colin R Goding
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

6.  Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells.

Authors:  David Cobrinik; Richard O Francis; David H Abramson; Thomas C Lee
Journal:  Mol Cancer       Date:  2006-12-12       Impact factor: 27.401

7.  Identification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element.

Authors:  Robert Alazard; Magali Blaud; Shmouel Elbaz; Christine Vossen; Guillaume Icre; Gérard Joseph; Laurence Nieto; Monique Erard
Journal:  Nucleic Acids Res       Date:  2005-03-14       Impact factor: 16.971

8.  Impact of Gender in Renal Cell Carcinoma: The Relationship of FABP7 and BRN2 Expression with Overall Survival.

Authors:  Cheng Tan; Tatsuya Takayama; Naohisa Takaoka; Hiromi Fujita; Miki Miyazaki; Takayuki Sugiyama; Seiichiro Ozono
Journal:  Clin Med Insights Oncol       Date:  2014-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.